PIAN MOY: Open Payments
NPI 1033762802 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,075 in 119 payments from 38 companies in 2025. Trend: 2023 $2,817 · 2024 $2,970 · 2025 $3,075
Food & beverage: $2,821Education: $254
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $410 |
| Astellas Pharma US Inc | 6 | $296 |
| Janssen Biotech, Inc. | 8 | $233 |
| AstraZeneca Pharmaceuticals LP | 5 | $130 |
| E.R. Squibb & Sons, L.L.C. | 5 | $126 |
| Incyte Corporation | 5 | $121 |
| ABBVIE INC. | 5 | $120 |
| Merck Sharp & Dohme LLC | 5 | $116 |
| JAZZ PHARMACEUTICALS INC. | 3 | $105 |
| PFIZER INC. | 5 | $97 |
Products named: KISQALI, ERLEADA, KEYTRUDA, OPDIVO, JAKAFI, clonoSEQ, ULTOMIRIS, LUTATHERA.
Industry payments across IL — which companies pay providers there.
